Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent.
作者信息
Ceccarelli Giancarlo, Alessandri Francesco, Oliva Alessandra, Dell'Isola Serena, Rocco Monica, Ruberto Franco, Pugliese Francesco, d'Ettorre Gabriella, Venditti Mario
机构信息
Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.
出版信息
Eur J Clin Invest. 2021 Jan;51(1):e13418. doi: 10.1111/eci.13418. Epub 2020 Oct 14.
Abstract
摘要
相似文献
1
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent.以替考拉宁作为抗SARS-CoV-2药物治疗的患者中的二重感染。
Eur J Clin Invest. 2021 Jan;51(1):e13418. doi: 10.1111/eci.13418. Epub 2020 Oct 14.
2
Bloodstream infections in critically ill patients with COVID-19.COVID-19 重症患者血流感染。
Eur J Clin Invest. 2020 Oct;50(10):e13319. doi: 10.1111/eci.13319. Epub 2020 Aug 11.
3
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.SARS-CoV-2 预防措施对 ESKAPE 和大肠杆菌感染的保护作用。
Eur J Clin Invest. 2021 Dec;51(12):e13687. doi: 10.1111/eci.13687. Epub 2021 Oct 11.
4
Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012.2006 - 2012年纽约医院系统中医疗保健相关感染的发病率及抗菌药物敏感性变化
J Prev Med Hyg. 2017 Dec 30;58(4):E294-E301. doi: 10.15167/2421-4248/jpmh2017.58.4.774. eCollection 2017 Dec.
5
Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.1994 - 2012年瑞典烧伤中心抗生素敏感性监测
Burns. 2016 Sep;42(6):1295-303. doi: 10.1016/j.burns.2016.01.025. Epub 2016 May 27.
6
Susceptibility pattern of tracheal tube isolates from Intensive Care Unit of Fauji Foundation Hospital Rawalpindi.拉瓦尔品第法吉基金会医院重症监护病房气管导管分离株的药敏模式。
J Pak Med Assoc. 2019 Jul;69(7):981-984.
7
Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.评估 ICU 收治的 COVID-19 患者呼吸道的细菌合并感染。
BMC Infect Dis. 2020 Sep 1;20(1):646. doi: 10.1186/s12879-020-05374-z.
8
Nosocomial bloodstream infections in a nationwide study: comparison between solid organ transplant patients and the general population.一项全国性研究中的医院血流感染：实体器官移植患者与普通人群的比较。
Transpl Infect Dis. 2015 Apr;17(2):308-13. doi: 10.1111/tid.12356. Epub 2015 Mar 2.
9
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.危重症患者医院获得性多重耐药革兰阴性杆菌感染的预测工具——前瞻性观察性研究
BMC Infect Dis. 2014 Nov 25;14:615. doi: 10.1186/s12879-014-0615-z.
10
Ventilator-associated pneumonia.呼吸机相关性肺炎
Semin Respir Crit Care Med. 2014 Aug;35(4):469-81. doi: 10.1055/s-0034-1384752. Epub 2014 Aug 11.
引用本文的文献
1
Association of Extended Steroid Treatment With Bloodstream Infection in Critically Ill Patients With COVID-19: A National, Multicenter, Propensity Score-Matched Study.新冠重症患者延长类固醇治疗与血流感染的关联：一项全国性、多中心、倾向评分匹配研究
J Korean Med Sci. 2025 May 26;40(20):e82. doi: 10.3346/jkms.2025.40.e82.
2
Prevention and treatment of ventilator-associated pneumonia in COVID-19.新型冠状病毒肺炎中呼吸机相关性肺炎的防治
Front Pharmacol. 2022 Oct 19;13:945892. doi: 10.3389/fphar.2022.945892. eCollection 2022.
3
Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control.在 COVID-19 大流行期间，导管相关血流感染的频率增加：呼吁进行控制。
J Hosp Infect. 2022 Jan;119:149-154. doi: 10.1016/j.jhin.2021.09.020. Epub 2021 Oct 8.
4
Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.165 例需插管的 COVID-19 肺炎患者痰培养中的细菌和真菌生长：抗菌药物耐药发展的证据及危险因素分析。
Ann Clin Microbiol Antimicrob. 2021 Sep 25;20(1):69. doi: 10.1186/s12941-021-00472-5.
5
Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies.严重急性呼吸综合征冠状病毒2感染（冠状病毒病2019）住院患者的医院获得性血流感染：与免疫抑制治疗的关联
Open Forum Infect Dis. 2021 Jun 30;8(7):ofab339. doi: 10.1093/ofid/ofab339. eCollection 2021 Jul.
6
Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19.在新冠肺炎期间持续存在的系统性微生物易位和肠道损伤。
Front Immunol. 2021 Jul 14;12:708149. doi: 10.3389/fimmu.2021.708149. eCollection 2021.
7
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission.对比需要入住重症监护病房的 COVID-19 患者和流感肺炎患者的临床特征和结局。
Infection. 2021 Oct;49(5):965-975. doi: 10.1007/s15010-021-01624-7. Epub 2021 May 26.
8
The importance of genomic analysis in cracking the coronavirus pandemic.基因组分析在破解冠状病毒大流行中的重要性。
Expert Rev Mol Diagn. 2021 Jun;21(6):547-562. doi: 10.1080/14737159.2021.1917998. Epub 2021 Apr 28.
9
Science's Response to CoVID-19.科学应对新冠病毒。
ChemMedChem. 2021 Aug 5;16(15):2288-2314. doi: 10.1002/cmdc.202100079. Epub 2021 Jun 22.
10
The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study).替考拉宁在治疗 SARS-CoV-2 感染中的作用：一项对危重症 COVID-19 患者的回顾性研究（Tei-COVID 研究）。
J Med Virol. 2021 Jul;93(7):4319-4325. doi: 10.1002/jmv.26925. Epub 2021 Mar 26.
本文引用的文献
1
Probiotics and COVID-19.益生菌与2019冠状病毒病
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):721-722. doi: 10.1016/S2468-1253(20)30196-5.
2
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19.托珠单抗治疗 COVID-19 机械通气患者。
Clin Infect Dis. 2021 Jul 15;73(2):e445-e454. doi: 10.1093/cid/ciaa954.
3
Bloodstream infections in critically ill patients with COVID-19.COVID-19 重症患者血流感染。
Eur J Clin Invest. 2020 Oct;50(10):e13319. doi: 10.1111/eci.13319. Epub 2020 Aug 11.
4
Is teicoplanin a complementary treatment option for COVID-19? The question remains.替考拉宁是新冠病毒病的一种辅助治疗选择吗？这个问题仍然存在。
Int J Antimicrob Agents. 2020 Aug;56(2):106029. doi: 10.1016/j.ijantimicag.2020.106029. Epub 2020 May 23.
5
Teicoplanin: an alternative drug for the treatment of COVID-19?替考拉宁：治疗 COVID-19 的一种替代药物？
Int J Antimicrob Agents. 2020 Apr;55(4):105944. doi: 10.1016/j.ijantimicag.2020.105944. Epub 2020 Mar 13.
6
The effect of antibiotics on the composition of the intestinal microbiota - a systematic review.抗生素对肠道微生物群落组成的影响——系统评价。
J Infect. 2019 Dec;79(6):471-489. doi: 10.1016/j.jinf.2019.10.008. Epub 2019 Oct 18.
7
Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy.治疗药物监测指导下评估替考拉宁的最佳剂量：过高易发生不良反应，过低则疗效不佳。
Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2113-2120. doi: 10.1007/s10096-019-03652-6. Epub 2019 Aug 1.
8
A catalogue of reporting guidelines for health research.健康研究报告规范目录。
Eur J Clin Invest. 2010 Jan;40(1):35-53. doi: 10.1111/j.1365-2362.2009.02234.x.
Zotero 插件